Gossamer Bio Inc
Gossamer Bio Inc (GOSS) Option Chain
Read more
Tracking the GOSS option chain helps you see every strike and expiry on Gossamer Bio Inc in one view, so you can quickly identify contracts that fit your thesis and your risk. It lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of GOSS options activity at a glance. Use our scanner to monitor the GOSS option chain in real time and filter for the trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For GOSS stock options, the chain shows call and put data side by side, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading it well means looking beyond the last price. Implied volatility by strike, volume to open interest ratios, and bid ask spreads all show where GOSS options are being actively traded, and where they are not.
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colonystimulating factor 1 receptor, or CSF1R, and c-KIT inhibitor for the treatment of pulmonary arterial hypertension; GB004, a gut-targeted, oral small molecule for the treatment of inflammatory bowel disease; GB5121, an oral, irreversible, covalent, small molecule inhibitor of Bruton's Tyrosine Kinase for the treatment of primary central nervous system lymphoma; and GB7208, an oral, small molecule, BTK inhibitor for the treatment of multiple sclerosis.
| CALLs | PUTs | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prob. OTM % | Open Interest | Volume | Extrinsic Value | Intrinsic Value | Bid | Ask | Strike | Moneyness % | Bid | Ask | Intrinsic Value | Extrinsic Value | Volume | Open Interest | Prob. OTM % |
| 96.62 | 2,399 | 28 | -10.88 | 10.93 | — | 0.05 | 0.50 | +257.14 | 0.25 | 0.40 | 0.00 | 0.33 | 2 | 221 | 3.38 |
| 99.50 | 10 | 0 | -10.38 | 10.43 | — | 0.05 | 1.00 | +614.29 | 0.80 | 3.70 | 0.00 | 2.25 | 0 | 19 | 0.50 |
| 99.87 | 9 | 0 | -5.73 | 9.93 | — | 4.20 | 1.50 | +971.43 | — | 1.40 | 0.00 | 1.40 | 0 | 0 | 0.13 |
| 99.95 | 0 | 0 | -5.23 | 9.43 | — | 4.20 | 2.00 | +1328.57 | — | 1.90 | 0.00 | 1.90 | 0 | 0 | 0.04 |
| 99.99 | 11 | 0 | -8.28 | 8.43 | — | 0.15 | 3.00 | +2042.86 | 0.05 | 2.90 | 0.00 | 1.48 | 0 | 2 | 0.01 |
As of Nov 17, 2026
Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →Stock Statistics
- IndustryBiotechnology
- SectorHealthcare
- IV Rank42.26% Moderate
- Market cap (M$)70
- 52 weeks high-96.38%
- 52 weeks low27.27%
- Analyst recommendationBuy
2.43 - Target price$1.66
-85.48% below the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-04
- P/E—
- Future P/E—
- EPS (ttm)-0.70
- EPS growth next 5 years46.48%
As of Nov 17, 2026